GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » PB Ratio

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) PB Ratio : 6.13 (As of May. 06, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-06), Sun Pharmaceuticals Industries's share price is ₹1529.15. Sun Pharmaceuticals Industries's Book Value per Share for the quarter that ended in Dec. 2023 was ₹249.34. Hence, Sun Pharmaceuticals Industries's PB Ratio of today is 6.13.

The historical rank and industry rank for Sun Pharmaceuticals Industries's PB Ratio or its related term are showing as below:

NSE:SUNPHARMA' s PB Ratio Range Over the Past 10 Years
Min: 1.99   Med: 4.26   Max: 8.42
Current: 6.13

During the past 13 years, Sun Pharmaceuticals Industries's highest PB Ratio was 8.42. The lowest was 1.99. And the median was 4.26.

NSE:SUNPHARMA's PB Ratio is ranked worse than
87.71% of 960 companies
in the Drug Manufacturers industry
Industry Median: 2.01 vs NSE:SUNPHARMA: 6.13

During the past 12 months, Sun Pharmaceuticals Industries's average Book Value Per Share Growth Rate was 12.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 7.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 7.00% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sun Pharmaceuticals Industries was 58.40% per year. The lowest was 5.10% per year. And the median was 23.70% per year.

Back to Basics: PB Ratio


Sun Pharmaceuticals Industries PB Ratio Historical Data

The historical data trend for Sun Pharmaceuticals Industries's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries PB Ratio Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.77 1.87 3.09 4.57 4.21

Sun Pharmaceuticals Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.21 - 4.65 -

Competitive Comparison of Sun Pharmaceuticals Industries's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharmaceuticals Industries's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's PB Ratio falls into.



Sun Pharmaceuticals Industries PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Sun Pharmaceuticals Industries's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1529.15/249.343
=6.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Sun Pharmaceuticals Industries  (NSE:SUNPHARMA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Sun Pharmaceuticals Industries PB Ratio Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description

Traded in Other Exchanges
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines

No Headlines